Citations

Citations to this article as recorded by  

• Multidimensional assessment of adverse events of bupropion: A large-scale data analysis from the FAERS database
  Rongrong Lu, Ying Jiang, Zhiqiang Du, Qin Zhou, Yuan Shen, Haohao Zhu
  Journal of Affective Disorders.2024; 354: 649.     CrossRef
• Clinical uses of Bupropion in patients with Parkinson’s disease and comorbid depressive or neuropsychiatric symptoms: a scoping review
  Matteo Vismara, Beatrice Benatti, Gregorio Nicolini, Ilaria Cova, Edoardo Monfrini, Alessio Di Fonzo, Vincenza Fetoni, Caterina A. Viganò, Alberto Priori, Bernardo Dell’Osso
  BMC Neurology.2022;[Epub]     CrossRef
• Experimental Dopamine Reuptake Inhibitors in Parkinson’s Disease: A Review of the Evidence
  Thomas Müller
  Journal of Experimental Pharmacology.2021; Volume 13: 397.     CrossRef